.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Teva
Chubb
Julphar
Daiichi Sankyo
AstraZeneca
Chinese Patent Office
Express Scripts
Merck
Colorcon

Generated: September 19, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,031,007 protect, and when does it expire?


Patent ► Subscribe protects ORAQIX and is included in one NDA.

This patent has thirty-two patent family members in twenty-nine countries.

Summary for Patent: ► Subscribe

Title: Pharmaceutical composition with anaesthetic effect
Abstract:The invention is directed to a novel pharmaceutical composition comprising one or more local anaesthetics in oil form, one or more surfactants, water and optionally a taste masking agent. The novel composition is advantageously used as a local anaesthetic for pain relief within the oral cavity.
Inventor(s): Brodin; Arne (Sodertalje, SE), Fynes; Raymond (Mississauga, CA), Heijl; Lars (Lerum, SE), Nyqvist-Mayer; Adela (Tullinge, SE), Scherlund; Marie (Bromma, SE)
Assignee: Astra AB (SE)
Application Number:08/875,888
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Dentsply Pharm
ORAQIX
lidocaine; prilocaine
GEL;PERIODONTAL021451-001Dec 19, 2003RXYesYes► Subscribe► SubscribeY MANAGEMENT OF PAIN AND DISCOMFORT ASSOCIATED WITH PERIDONTAL SCALING AND ROOT PLANNING PROCEDURES BY APPLICATION OF AN EUTECTIC MIXTURE OF LOCAL ANESTHETICS TO PERIDONTAL POCKETS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9601421Apr 12, 1996
PCT Information
PCT FiledApril 01, 1997PCT Application Number:PCT/SE97/00566
PCT Publication Date:October 23, 1997PCT Publication Number: WO97/38675

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain2203799► Subscribe
Hong Kong1010144► Subscribe
Hungary9903544► Subscribe
Indonesia16420► Subscribe
Israel122447► Subscribe
Iceland4618► Subscribe
JapanH11501678► Subscribe
Japan2004149544► Subscribe
Mexico9709941► Subscribe
Norway975831► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
McKinsey
McKesson
Colorcon
Healthtrust
Express Scripts
Federal Trade Commission
Merck
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot